Guillevin L - Search Results

1

[Pathogenesis of primary systemic vasculitides (II): ANCA-negative vasculitides].

Guilpain P, Servettaz A, Tamby MC, Chanseaud Y, Le Guern V, Guillevin L, Mouthon L. Guilpain P, et al. Among authors: guillevin l. Presse Med. 2005 Aug 27;34(14):1023-33. doi: 10.1016/s0755-4982(05)84105-3. Presse Med. 2005. PMID: 16225258 Review. French.

2

[Intravenous immunoglobulins: therapeutic indications].

Mouthon L, Berezné A, Le Guern V, Guillevin L. Mouthon L, et al. Among authors: guillevin l. Presse Med. 2005 Sep 24;34(16 Pt 1):1166-75. doi: 10.1016/s0755-4982(05)84144-2. Presse Med. 2005. PMID: 16208266 Review. French.

3

[Pathogenesis of primary systemic vasculitides (I): ANCA-positive vasculitides].

Guilpain P, Chanseaud Y, Tamby MC, Mahr A, Servettaz A, Guillevin L, Mouthon L. Guilpain P, et al. Among authors: guillevin l. Presse Med. 2005 Aug 27;34(14):1013-22. doi: 10.1016/s0755-4982(05)84104-1. Presse Med. 2005. PMID: 16225257 Review. French.

4

How to optimize the treatment of systemic vasculitides.

Guillevin L, Lhote F, Mouthon L, Cohen P. Guillevin L, et al. Ann Med Interne (Paris). 2000 May;151(3):199-206. Ann Med Interne (Paris). 2000. PMID: 10896972 Review. No abstract available.

5

Lack of association between B19 or V9 erythrovirus infection and ANCA-positive vasculitides: a case-control study.

Eden A, Mahr A, Servant A, Radjef N, Amard S, Mouthon L, Garbarg-Chenon A, Guillevin L. Eden A, et al. Among authors: guillevin l. Rheumatology (Oxford). 2003 May;42(5):660-4. doi: 10.1093/rheumatology/keg206. Rheumatology (Oxford). 2003. PMID: 12709542

6

[Pathogenesis of ANCA-positive vasculitides: recent advances].

Mouthon L, Guillevin L. Mouthon L, et al. Among authors: guillevin l. Rev Med Interne. 2003 Sep;24(9):557-9. doi: 10.1016/s0248-8663(03)00169-3. Rev Med Interne. 2003. PMID: 12951175 French. No abstract available.

7

[Eosinophil granule cationic proteins: eosinophil activation markers].

Guilpain P, Guillevin L, Mouthon L. Guilpain P, et al. Among authors: guillevin l. Rev Med Interne. 2006 May;27(5):406-8. doi: 10.1016/j.revmed.2006.01.008. Epub 2006 Feb 9. Rev Med Interne. 2006. PMID: 16510214 French.

8

Antibodies to fibroblasts in idiopathic and scleroderma-associated pulmonary hypertension.

Tamby MC, Humbert M, Guilpain P, Servettaz A, Dupin N, Christner JJ, Simonneau G, Fermanian J, Weill B, Guillevin L, Mouthon L. Tamby MC, et al. Among authors: guillevin l. Eur Respir J. 2006 Oct;28(4):799-807. doi: 10.1183/09031936.06.00152705. Epub 2006 Jun 14. Eur Respir J. 2006. PMID: 16774952 Free article.

9

Antifibroblast antibodies from systemic sclerosis patients bind to {alpha}-enolase and are associated with interstitial lung disease.

Terrier B, Tamby MC, Camoin L, Guilpain P, Bérezné A, Tamas N, Broussard C, Hotellier F, Humbert M, Simonneau G, Guillevin L, Mouthon L. Terrier B, et al. Among authors: guillevin l. Ann Rheum Dis. 2010 Feb;69(2):428-33. doi: 10.1136/ard.2008.104299. Epub 2009 Mar 16. Ann Rheum Dis. 2010. PMID: 19293162

10

[Pathogenic role of antimyeloperoxidase antibodies].

Guilpain P, Maldini C, Guillevin L. Guilpain P, et al. Among authors: guillevin l. Rev Med Interne. 2011 Jul;32(7):411-5. doi: 10.1016/j.revmed.2010.05.005. Epub 2010 Jul 14. Rev Med Interne. 2011. PMID: 20633964 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,146 results

Search Page